- Home
- GHRS vs SLRC Comparison
GHRS vs SLRC Comparison
Compare GHRS & SLRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- SLRC
- Stock Information
- Founded
- GHRS 2018
- SLRC 2007
- Country
- GHRS Ireland
- SLRC United States
- Employees
- GHRS N/A
- SLRC N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- SLRC Finance/Investors Services
- Sector
- GHRS Health Care
- SLRC Finance
- Exchange
- GHRS Nasdaq
- SLRC Nasdaq
- Market Cap
- GHRS 892.0M
- SLRC 771.9M
- IPO Year
- GHRS 2021
- SLRC 2010
- Fundamental
- Price
- GHRS $14.38
- SLRC $15.60
- Analyst Decision
- GHRS Strong Buy
- SLRC Hold
- Analyst Count
- GHRS 9
- SLRC 7
- Target Price
- GHRS $30.11
- SLRC $16.04
- AVG Volume (30 Days)
- GHRS 407.8K
- SLRC 276.9K
- Earning Date
- GHRS 11-06-2025
- SLRC 11-04-2025
- Dividend Yield
- GHRS N/A
- SLRC 10.53%
- EPS Growth
- GHRS N/A
- SLRC N/A
- EPS
- GHRS N/A
- SLRC 1.65
- Revenue
- GHRS N/A
- SLRC $219,666,000.00
- Revenue This Year
- GHRS N/A
- SLRC N/A
- Revenue Next Year
- GHRS N/A
- SLRC $0.23
- P/E Ratio
- GHRS N/A
- SLRC $9.44
- Revenue Growth
- GHRS N/A
- SLRC N/A
- 52 Week Low
- GHRS $6.72
- SLRC $13.64
- 52 Week High
- GHRS $20.50
- SLRC $17.94
- Technical
- Relative Strength Index (RSI)
- GHRS 55.96
- SLRC 59.50
- Support Level
- GHRS $13.71
- SLRC $14.81
- Resistance Level
- GHRS $15.01
- SLRC $15.12
- Average True Range (ATR)
- GHRS 0.98
- SLRC 0.31
- MACD
- GHRS 0.04
- SLRC 0.01
- Stochastic Oscillator
- GHRS 74.17
- SLRC 89.66
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About SLRC SLR Investment Corp.
SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. It invests majorly in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities.